Challenges in bringing the bench to bedside in drug development for SLE.

Challenges in bringing the bench to bedside in drug development for SLE.

Item
http://www.wikidata.org/entity/Q35968394
The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectinBLyS antagonists and peptide tolerance induction.B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus.Belimumab in systemic lupus erythematosus: an update for clinicians.Developments in the scientific understanding of lupus.Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trialA phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosisNanomaterials, Autophagy, and Lupus Disease.The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus.Systemic lupus erythematosus: clinical manifestations, treatment and economics.A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity
P2860

Challenges in bringing the bench to bedside in drug development for SLE.

Item
http://www.wikidata.org/entity/Q35968394
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Challenges in bringing the bench to bedside in drug development for SLE.
@ast
Challenges in bringing the bench to bedside in drug development for SLE.
@en
type
label
Challenges in bringing the bench to bedside in drug development for SLE.
@ast
Challenges in bringing the bench to bedside in drug development for SLE.
@en
prefLabel
Challenges in bringing the bench to bedside in drug development for SLE.
@ast
Challenges in bringing the bench to bedside in drug development for SLE.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Challenges in bringing the bench to bedside in drug development for SLE.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698